SARS-CoV-2 (Omicron variant) vaccine, Inactivated (Sinovac)

Omicron株新型冠状病毒灭活疫苗（科兴生物）

Report date: 2022/07/04 19:38:02

Base Information

Drug NameSARS-CoV-2 (Omicron variant) vaccine, Inactivated (Sinovac)
Drug Alias NameCOVID-19 Vaccine (Vero cell), Inactivated (Omicron variant)
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Influenza B virus infection
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryChileHong KongMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesSinovac Biotech (Hong Kong) Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSinovac Research And Development Co LtdSinovac Biotech (Hong Kong) LtdPontificia Universidad Catolica De Chile +[4] 
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Influenza B virus infection
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A